Aptorum Group Limited (APM)
NASDAQ: APM · Real-Time Price · USD
0.7899
-0.0100 (-1.25%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Aptorum Group Market Cap
Aptorum Group has a market cap or net worth of $6.43 million as of March 9, 2026. Its market cap has decreased by -18.88% in one year.
Market Cap
6.43M
Enterprise Value
7.67M
1-Year Change
-18.88%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since December 18, 2018, Aptorum Group's market cap has decreased from $415.79M to $6.43M, a decrease of -98.45%. That is a compound annual growth rate of -43.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 6.51M | -24.54% |
| Dec 31, 2025 | 8.63M | -45.03% |
| Dec 31, 2024 | 15.70M | 23.78% |
| Dec 29, 2023 | 12.69M | -35.41% |
| Dec 30, 2022 | 19.64M | -63.24% |
| Dec 31, 2021 | 53.44M | -36.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moolec Science | 6.87M |
| Addex Therapeutics | 6.85M |
| Immuron | 6.84M |
| XTL Biopharmaceuticals | 6.73M |
| Creative Medical Technology Holdings | 6.57M |
| Mustang Bio | 6.54M |
| Can-Fite BioPharma | 6.45M |
| Theriva Biologics | 6.45M |